Articles

Liver cancer: how Europe can halt the rising death toll

When the cancer community in Europe talks of neglected cancers it usually means relatively rare or uncommon types, of which there are many. But conspicuous in the list are two digestive cancers…

Articles

Trust me: I’m a surgical oncologist!

Surgery has been the mainstay for treating solid tumours since the dawn of cancer treatment, and recent decades have seen a huge increase in the complexity and multidisciplinary demands of carrying out…

Profiles

Mike Morrissey: At your service

The European cancer community has long had its ups and downs in its efforts to act in concert to promote policy and standards throughout its constituent countries, which differ widely in their…

Obituaries

José Baselga: A giant of medical oncology

José Baselga, one of the most high profile oncologists of recent times, has died at the age of 61. His fame in the cancer world is confirmed by the volume of tributes…

Articles

Immunotherapy toxicities demand a joined up approach from oncologists and organ specialists

Adverse effects of cancer therapies have long been at the root of decision making for interventions in all modalities – surgery, radiotherapy and medical – and especially in the latter category of…

Articles

EMA at 25: learning more from cancer patients

Responsibility for scientific evaluation, supervision and safety monitoring of medicines was done at the national level until 1995, when EU member states agreed to coordinate that work within the European Medicines Agency…

Articles

Rapid palliation of bone mets: it’s effective and easy, so why aren’t we all doing it?

Bone metastases occur in around 7 out of every 10 people with advanced cancer, and are most frequently found in people with breast, prostate, lung or kidney cancers, and in most people…

Articles

Could covid-19 boost interest in drug repurposing in oncology?

Could the frantic search for drugs to treat patients severely affected by the covid-19 virus be a shot in the arm for new cancer treatments? There have been many headlines about repurposed agents, such as the highly debated antimalarial drug hydroxychloroquine or tocilizumab, an anti-rheumatic drug targeting Il-6. Along with many others, the research to […]

Obituaries

Karen Benn: a great example of what an advocate can accomplish

Tributes have poured in for Karen Benn, deputy CEO and head of public affairs at Europa Donna, who died on 4 September. Karen was one of the longest serving officers at Europa Donna, the European Breast Cancer Coalition that unites advocacy in Europe, having joined in 2003 after working in the business sector for a […]

Articles

Does it work for my patient? A pragmatic approach to building evidence on clinical effectiveness

Should patients be at the centre of attention in the development of new cancer drugs? It might seem extraordinary that this question is even asked – what else matters? But it is a question high on the agenda of the European Organisation for Research and Treatment of Cancer (EORTC), the pan-European non-profit agency, in its […]